PL1868642T3 - Białka fuzyjne alergenów kocich i ich zastosowania - Google Patents

Białka fuzyjne alergenów kocich i ich zastosowania

Info

Publication number
PL1868642T3
PL1868642T3 PL06725140T PL06725140T PL1868642T3 PL 1868642 T3 PL1868642 T3 PL 1868642T3 PL 06725140 T PL06725140 T PL 06725140T PL 06725140 T PL06725140 T PL 06725140T PL 1868642 T3 PL1868642 T3 PL 1868642T3
Authority
PL
Poland
Prior art keywords
fusion proteins
cat allergen
allergen fusion
cat
proteins
Prior art date
Application number
PL06725140T
Other languages
English (en)
Inventor
Martin Bachmann
Monika Bauer
Klaus Dietmeier
Nicole Schmitz
Stephan Utzinger
Original Assignee
Cytos Biotechnology Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytos Biotechnology Ag filed Critical Cytos Biotechnology Ag
Publication of PL1868642T3 publication Critical patent/PL1868642T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL06725140T 2005-03-18 2006-03-17 Białka fuzyjne alergenów kocich i ich zastosowania PL1868642T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66291805P 2005-03-18 2005-03-18
EP06725140.5A EP1868642B1 (en) 2005-03-18 2006-03-17 Cat allergen fusion proteins and uses thereof
PCT/EP2006/060845 WO2006097530A2 (en) 2005-03-18 2006-03-17 Cat allergen fusion proteins and uses thereof

Publications (1)

Publication Number Publication Date
PL1868642T3 true PL1868642T3 (pl) 2013-10-31

Family

ID=36843236

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06725140T PL1868642T3 (pl) 2005-03-18 2006-03-17 Białka fuzyjne alergenów kocich i ich zastosowania

Country Status (19)

Country Link
US (3) US7767212B2 (pl)
EP (1) EP1868642B1 (pl)
JP (2) JP5302671B2 (pl)
KR (1) KR20070112225A (pl)
CN (2) CN103203016A (pl)
AU (1) AU2006224529B2 (pl)
BR (1) BRPI0608455A2 (pl)
CA (1) CA2599218C (pl)
CY (1) CY1114171T1 (pl)
DK (1) DK1868642T3 (pl)
ES (1) ES2424229T3 (pl)
IL (1) IL185103A0 (pl)
MX (1) MX2007011160A (pl)
NZ (1) NZ561040A (pl)
PL (1) PL1868642T3 (pl)
PT (1) PT1868642E (pl)
RU (1) RU2414239C2 (pl)
WO (1) WO2006097530A2 (pl)
ZA (1) ZA200707413B (pl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7264810B2 (en) * 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
WO2003024481A2 (en) 2001-09-14 2003-03-27 Cytos Biotechnology Ag Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
EP2351770A1 (en) * 2002-07-17 2011-08-03 Cytos Biotechnology AG Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
AU2003250110C1 (en) * 2002-07-19 2008-05-29 Novartis Ag Vaccine compositions containing amyloid beta1-6 antigen arrays
PL1868642T3 (pl) * 2005-03-18 2013-10-31 Cytos Biotechnology Ag Białka fuzyjne alergenów kocich i ich zastosowania
NZ569741A (en) * 2005-12-14 2012-02-24 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
WO2007113633A2 (en) * 2006-04-03 2007-10-11 Pfizer Products Inc. Immunogenic compositions comprising cat allergen fel dl
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
ES2427994T3 (es) 2006-06-12 2013-11-05 Cytos Biotechnology Ag Procesos para empaquetar oligonucleótidos en partículas de tipo viral de bacteriófagos de ARN
EP2601970B1 (en) 2006-09-29 2016-10-26 Takeda Vaccines, Inc. Norovirus vaccine formulations
US9388236B2 (en) 2007-07-09 2016-07-12 Nestec Sa Methods for reducing allergies caused by environmental allergens
HUE034431T2 (en) 2007-07-09 2018-02-28 Nestec Sa Procedures to reduce allergies caused by environmental allergens
EP2190471A4 (en) 2007-09-18 2012-05-09 Ligocyte Pharmaceuticals Inc METHOD FOR TRANSFERRING A PROTECTIVE REACTION ON NOROVIRES
US20100266636A1 (en) 2007-09-18 2010-10-21 Ligocyte Pharmaceuticals, Inc. Method of conferring a protective immune response to norovirus
EP2042193A1 (en) * 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
AU2009279456B2 (en) 2008-08-08 2015-02-05 Takeda Vaccines, Inc. Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
CA2816401C (en) * 2009-11-05 2017-07-18 Novici Biotech Llc Generation of antigenic virus-like particles through protein-protein linkages
US8321012B2 (en) * 2009-12-22 2012-11-27 The Invention Science Fund I, Llc Device, method, and system for neural modulation as vaccine adjuvant in a vertebrate subject
EP2731621B1 (en) 2011-07-11 2017-11-01 Takeda Vaccines, Inc. Parenteral norovirus vaccine formulations
CA2854246A1 (en) 2011-12-22 2013-06-27 F. Hoffmann-La Roche Ag Full length antibody display system for eukaryotic cells and its use
JO3820B1 (ar) 2012-05-03 2021-01-31 Regeneron Pharma أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها
WO2014066443A1 (en) * 2012-10-23 2014-05-01 Emory University Gm-csf and il-4 conjugates, compositions, and methods related thereto
EP3564671B1 (en) 2013-08-23 2021-09-29 Regeneron Pharmaceuticals, Inc. Diagnostic tests and methods for assessing safety, efficacy or outcome of allergen-specific immunotherapy (sit)
MX2016007960A (es) * 2013-12-19 2016-09-09 Nestec Sa Composiciones y metodos para reducir los alegernos de gato en el medio ambiente.
MA40824A (fr) * 2014-10-22 2017-08-29 Saiba Gmbh Particules de cmv de type virus modifié
CA3010975A1 (en) 2015-01-15 2016-07-21 University Of Copenhagen Virus-like particle with efficient epitope display
WO2016192788A1 (en) * 2015-06-03 2016-12-08 Universität Zürich Prorektorat Mnw Methods and compositions for preventing and treating cat or dog dander allergy
US10835600B2 (en) * 2015-09-08 2020-11-17 Universität Zürich Compositions against cat allergy
US11129882B2 (en) 2015-10-30 2021-09-28 University Of Copenhagen Virus like particle with efficient epitope display
CN105219742A (zh) * 2015-11-10 2016-01-06 海南大学 一种展示重组猫致敏原rFel d 1蛋白的免疫增强型病毒样颗粒、其表达载体及其制备与应用
WO2017179025A1 (en) 2016-04-15 2017-10-19 Alk-Abelló A/S Epitope polypeptides of ragweed pollen allergens
FR3054547B1 (fr) * 2016-07-29 2020-06-05 Angany Inc. Particules pseudo-virales et leurs utilisations
EP3558347A1 (en) 2016-12-22 2019-10-30 Regeneron Pharmaceuticals, Inc. Method of treating an allergy with allergen-specific monoclonal antibodies
JP2022513452A (ja) 2018-12-20 2022-02-08 サイバ アクチェンゲゼルシャフト 融合によって修飾されたｃｍｖのウイルス様粒子
WO2023176206A1 (ja) * 2022-03-18 2023-09-21 デンカ株式会社 リンカーにより連結されたカプシドタンパク質を含むウイルス様粒子
CN114933639B (zh) * 2022-05-05 2023-12-29 中国农业科学院兰州兽医研究所 非洲猪瘟病毒p72N抗原表位蛋白及其制备方法和用途
CN117004650B (zh) * 2023-06-25 2024-05-14 山东立菲生物产业有限公司 一种猫皮屑过敏原组分feld1双链二聚体重组蛋白、制备方法及应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163778A (en) * 1978-05-04 1979-08-07 The Foundation for the Study of Asthma and Related Diseases Asthma immunotherapy
US5374426A (en) 1986-09-03 1994-12-20 University Of Saskatchewan Rotavirus nucleocapsid protein VP6 in vaccine compositions
AU633007B2 (en) 1988-06-14 1993-01-21 Cell-Sci Corporation Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
US6120769A (en) 1989-11-03 2000-09-19 Immulogic Pharmaceutical Corporation Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor
AU9052091A (en) 1990-12-20 1992-07-22 Smithkline Beecham Biologicals (Sa) Vaccines based on hepatitis b surface antigen
GB9114003D0 (en) 1991-06-28 1991-08-14 Mastico Robert A Chimaeric protein
GB9213601D0 (en) 1992-06-26 1992-08-12 Mastico Robert A Protein based delivery system
CZ63297A3 (en) 1994-09-02 1997-08-13 Immulogic Pharma Corp Peptide preparations capable of attenuating antigen specific immune response
US6759234B1 (en) 1994-09-02 2004-07-06 Immulogic Pharmaceutical Corporation Compositions and methods for administering to humans, peptides capable of down regulating an antigen specific immune response
WO1996030523A2 (en) 1995-03-31 1996-10-03 Hans Wolf Antigen presentation system based on retrovirus-like particles
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
US6054312A (en) 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
CA2315537A1 (en) 1997-12-16 1999-06-24 Regents Of The University Of Minnesota Methods to treat undesirable immune responses
AR020102A1 (es) 1998-07-30 2002-04-10 Ucb Sa Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento
WO2000020032A1 (en) 1998-10-06 2000-04-13 Trustees Of Dartmouth College RECOMBINANT CAT ALLERGEN, Fel dI, EXPRESSED IN BACULOVIRUS FOR DIAGNOSIS AND TREATMENT OF CAT ALLERGY
ES2258869T3 (es) 1998-10-21 2006-09-01 The United States Government As Represented By The Department Of Health And Human Services Particulas similares a virus para la induccion de autoanticuerpos.
CA2354183A1 (en) * 1998-11-30 2000-06-08 Cytos Biotechnology Ag Ordered molecular presentation of antigens, method of preparation and use
AP1775A (en) 1999-09-25 2007-08-28 Univ Iowa Res Found Immunostimulatory nucleic acids.
EP1278542A2 (en) * 2000-05-05 2003-01-29 Cytos Biotechnology AG Molecular antigen arrays and vaccines
AU2002223505B2 (en) 2000-11-16 2006-12-07 Alk-Abello A/S Mutant allergens
DK1219300T3 (da) 2000-12-28 2007-03-05 Biomay Prod & Handel Behandling af allergi
EP1221317A1 (en) 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
US7264810B2 (en) 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
ATE448793T1 (de) 2001-03-02 2009-12-15 Univ Rockefeller Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens
US20030091593A1 (en) 2001-09-14 2003-05-15 Cytos Biotechnology Ag In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
WO2003024481A2 (en) 2001-09-14 2003-03-27 Cytos Biotechnology Ag Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
DE60229659D1 (de) * 2001-11-07 2008-12-11 Cytos Biotechnology Ag Antigen-raster enthaltend rankl zur behandlung von knochenerkrankungen
AU2002363382B2 (en) * 2001-11-07 2007-07-19 Cytos Biotechnology Ag Antigen arrays presenting IL-5, IL-3 or eotaxin for treatment of allergic eosinophilic diseases
EP2351770A1 (en) * 2002-07-17 2011-08-03 Cytos Biotechnology AG Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
BR0311800A (pt) 2002-07-19 2005-03-22 Cytos Biotechnology Ag Conjugados ghrelina-veìculo
EP1530585A2 (en) 2002-08-22 2005-05-18 Cytos Biotechnology AG Inducible alphaviral/orip based gene expression system
CN1714153A (zh) 2002-11-01 2005-12-28 阿尔克-阿贝洛有限公司 重组蛋白质变异体
MXPA05005528A (es) 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.
RU2351362C2 (ru) * 2003-03-26 2009-04-10 Цитос Байотекнолоджи Аг КОНЪЮГАТЫ ПЕПТИДА Melan-A, АНАЛОГА ВИРУСОПОДОБНОЙ ЧАСТИЦЫ
WO2004094639A2 (en) 2003-04-24 2004-11-04 Im Vision Gmbh Recombinant fel d 1 allergen
AU2004255470B2 (en) * 2003-07-10 2010-08-19 Cytos Biotechnology Ag Packaged virus-like particles
PL1868642T3 (pl) * 2005-03-18 2013-10-31 Cytos Biotechnology Ag Białka fuzyjne alergenów kocich i ich zastosowania

Also Published As

Publication number Publication date
AU2006224529B2 (en) 2012-05-24
CA2599218A1 (en) 2006-09-21
CN103203016A (zh) 2013-07-17
CY1114171T1 (el) 2016-08-31
IL185103A0 (en) 2007-12-03
AU2006224529A1 (en) 2006-09-21
DK1868642T3 (da) 2013-06-24
JP5302671B2 (ja) 2013-10-02
US7767212B2 (en) 2010-08-03
US20130344098A1 (en) 2013-12-26
CN101141979B (zh) 2013-05-08
CA2599218C (en) 2015-08-11
EP1868642A2 (en) 2007-12-26
WO2006097530A3 (en) 2007-06-21
ZA200707413B (en) 2009-01-28
EP1868642B1 (en) 2013-05-08
PT1868642E (pt) 2013-07-10
ES2424229T3 (es) 2013-09-30
BRPI0608455A2 (pt) 2010-01-05
US20090175896A1 (en) 2009-07-09
JP2008535800A (ja) 2008-09-04
JP2013155176A (ja) 2013-08-15
WO2006097530A2 (en) 2006-09-21
RU2414239C2 (ru) 2011-03-20
MX2007011160A (es) 2007-11-13
CN101141979A (zh) 2008-03-12
RU2007138265A (ru) 2009-04-27
NZ561040A (en) 2009-04-30
US20110045013A1 (en) 2011-02-24
KR20070112225A (ko) 2007-11-22

Similar Documents

Publication Publication Date Title
ZA200707413B (en) Cat allergen fusion proteins and uses thereof
IL235620A0 (en) sp35 antibodies and their uses
IL222922A (en) Antibodies against neurophilin-1 and their use
PL1830872T3 (pl) Białka fuzyjne
GB0426397D0 (en) Fusion proteins
IL189246A0 (en) Albumin fusion proteins
PT2650020T (pt) Proteína de fusão de imunoglobulina ox-40 trimérica e métodos do campo de utilização
AP2008004471A0 (en) Anti-Alpha2 Intergin antibodies and their uses
EP2007884A4 (en) ENZYMATIC FUSION PROTEINS AND THEIR USE
EP1934372A4 (en) SSB-POLYMERASE HYBRID PROTEINS
IL184024A0 (en) Irta-5 antibodies and their uses
EP1960523A4 (en) MODIFIED POREN FORMING PROTEIN TOXINS AND USE THEREOF
ZA200801224B (en) Albumin fusion proteins
EP1904845A4 (en) IMPROVED RESULTS AND APPLICATION OF COMPARISON EXAMPLES OF PROTEIN EXPRESSIONS
EP1878801A4 (en) Protein splitting method and use thereof
GB0513878D0 (en) Cat allergen
EP1877425A4 (en) FLUORESCENT PROTEINS AND ITS USE
ZA200808656B (en) Enzyme fusion proteins and their use
SI1868642T1 (sl) Mačji alergen-fuzijski proteini in njihove uporabe
GB0417390D0 (en) Chimeric proteins and uses thereof
IL179998A0 (en) Chimeric proteins and uses thereof
HK1082770A1 (en) Supter-antigen fusion proteins and the use thereof
GB0426399D0 (en) Fusion proteins
AU2004901156A0 (en) Cat allergen
AU2004902079A0 (en) Cat allergen